Gilead Sciences to Present at Two Upcoming Investor Conferences
- 15^th Annual BIO CEO & Investor Conference on February 12^th -
- Leerink Swann Global Healthcare Conference 2013 on February 13^th -
- Webcasts Available Through Gilead Corporate Website -
BIO CEO & Investor Conference 2013 Leerink Swann Global Heathcare Conference
FOSTER CITY, Calif. -- February 11, 2013
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that the company will be
webcasting its corporate presentation at two upcoming investor conferences:
the BIO CEO & Investor Conference and the Leerink Swann Global Healthcare
Conference 2013, both taking place in New York.
John F. Milligan, PhD, Gilead’s President and Chief Operating Officer, will
provide an overview of the company at the BIO conference on Tuesday, February
12 at 11:00 a.m. Eastern Time (ET) and the Leerink Swann conference on
Wednesday, February 13 at 10:30 a.m. ET.
To access the live webcasts or replays via the internet log on to
www.gilead.com. Please connect to the company’s website at least 15 minutes
prior to the start of the presentation to ensure adequate time for any
software download that may be necessary to listen to the webcast. The replay
will be available for 14 days following the presentation.
Gilead Sciences is a biopharmaceutical company that discovers, develops and
commercializes innovative therapeutics in areas of unmet medical need. The
company’s mission is to advance the care of patients suffering from
life-threatening diseases worldwide. Headquartered in Foster City, California,
Gilead has operations in North America, Europe and Asia Pacific.
For more information on Gilead Sciences, please visit www.gilead.com or call
the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).
Gilead Sciences, Inc.
Patrick O’Brien, 650-522-1936
Press spacebar to pause and continue. Press esc to stop.